Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
SKYSTAR BIO-PHARM Add to My Watchlist (NSDQ: SKBI) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Skystar 8.50 +0.28 (+3.41%) 32,583
Rm.10601, Jiezuo Plaza, No.4
F.Road South,Gaoxin District
Xian Province, CI
862988193188
fax
www.skystarbio-pharmaceutical.com
CEO Mr. Weibing Lu
Auditor Moore Stephens Wurth Frazer and Torbet, LLP
Exchange Traded NQ
ISIN Number US8308843007
CIK Number 1076939
NAICS Code 325412
Business Summary
A holding company that, through its variable interest entity Xian Tianxing Bio-Pharmaceutical Co., Ltd. develops, manufactures and distributes medicines, vaccines and other health care and medical care products for poultry, livestock and domestic pet
Number of Employees 226
Share Fundamentals
Market Cap 59.35M
Shares Outstanding 6.98M
Float 5.82M
Short Interest 22.18K
Financial Strength
Revenue (TTM) $31,212,734
Earnings (TTM) $7,935,207
Quick Ratio 6.2:1
Current Ratio 9.6:1
Total Debt/Equity 0.01:1
Profitability
Gross Margin 52.5%
EBITDA Margin 33.7%
Profit Margin 31.3%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Real Time Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs